AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer-MedSci.cn

AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer

Bardia, A; Chandarlapaty, S; Linden, HM; Ulaner, GA; Gosselin, A; Cartot-Cotton, S; Cohen, P; Doroumian, S; Paux, G; Celanovic, M; Pelekanou, V; Ming, JE; Ternes, N; Bouaboula, M; Lee, JS; Bauchet, AL; Campone, M

Campone, M (通讯作者)，Inst Cancerol Ouest, Rene Gauducheau, Saint Herblain, France.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer

科室

工具

服务